BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4147516)

  • 1. Controlled clinical evaluation of depot neuroleptics. A double-blind trial with pipotiazine undecylenate and fluphenazine enanthate.
    Ahlfors UG
    Acta Psychiatr Scand Suppl; 1973; 241():95-9. PubMed ID: 4147516
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical evaluation of a new depot neuroleptic. A pilot study with pipotiazine undecylenate (19.551 R.P.).
    Ahlfors UG; Katila O
    Acta Psychiatr Scand Suppl; 1973; 241():43-9. PubMed ID: 4147510
    [No Abstract]   [Full Text] [Related]  

  • 3. A controlled one-year study of pipotiazine palmitate and fluphenazine decanoate in chronic schizophrenic syndromes. Evaluation of results at 6 and 12 months' trial.
    Dencker SJ; Frankenberg K; Malm U; Zell B
    Acta Psychiatr Scand Suppl; 1973; 241():101-18. PubMed ID: 4147508
    [No Abstract]   [Full Text] [Related]  

  • 4. Review of clinical trials with pipotiazine, pipotiazine undecylenate and pipotiazine palmitate.
    Brown-Thomsen J
    Acta Psychiatr Scand Suppl; 1973; 241():119-38. PubMed ID: 4151807
    [No Abstract]   [Full Text] [Related]  

  • 5. A double-blind controlled study of pipothiazine palmitate in the maintenance treatment of schizophrenic outpatients.
    Chouinard G; Annable L; Kropsky M
    J Clin Pharmacol; 1978; 18(2-3):148-54. PubMed ID: 24061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind comparative trial of the decanoates of clopenthixol and fluphenazine in the treatment of chronic schizophrenic out-patients.
    Walker CA
    Pharmatherapeutica; 1983; 3(5):289-93. PubMed ID: 6133287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depot fluphenazine decanoate and enanthate for schizophrenia.
    David A; Adams CE; Eisenbruch M; Quraishi S; Rathbone J
    Cochrane Database Syst Rev; 2005 Jan; (1):CD000307. PubMed ID: 15674872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standard and long-acting depot neuroleptics in chronic schizophrenics: an 18-month open multicentric study.
    Simon P; Fermanian J; Ginestet D; Goujet MA; Péron-Magnan P
    Arch Gen Psychiatry; 1978 Jul; 35(7):893-7. PubMed ID: 28102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluphenazine enanthate and fluphenazine decanoate in the treatment of schizophrenic outpatients: extrapyramidal symptoms and therapeutic effect.
    Chouinard G; Annable L; Ross-Chouinard A
    Am J Psychiatry; 1982 Mar; 139(3):312-8. PubMed ID: 6120655
    [No Abstract]   [Full Text] [Related]  

  • 10. Pipotiazine palmitate (19.552 R.P.) in the long-term treatment of chronic psychoses. A controlled trial on in-patients.
    Robak OH
    Acta Psychiatr Scand Suppl; 1973; 241():83-94. PubMed ID: 4147515
    [No Abstract]   [Full Text] [Related]  

  • 11. High doses of fluphenazine enanthate in schizophrenia. A controlled study.
    Dencker SJ; Johansson R; Lundin L; Malm U
    Acta Psychiatr Scand; 1978 May; 57(5):405-14. PubMed ID: 354329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative study of delayed-action neuroleptics in psychiatric therapeutics].
    Pellet J; Guyotat J; Marie-Cardine M; Dubor P; Favre-Tissot M; Caron F; Cottraux J
    J Med Lyon; 1972 Apr; 53(227):591-8. PubMed ID: 4404295
    [No Abstract]   [Full Text] [Related]  

  • 13. Differential study of 2 long-acting neuroleptics, fluphenazine enanthate and pipothiazine undecylenate.
    Gayral LF; Escande MM; Fournie HC; Huron RJ
    Therapie; 1973; 28(3):611-25. PubMed ID: 4771904
    [No Abstract]   [Full Text] [Related]  

  • 14. How schizophrenic patients change during 3 years' treatment with depot neuroleptics.
    Dencker SJ; Frankenberg K; Lepp M; Lindberg D; Malm U
    Acta Psychiatr Scand; 1978 Feb; 57(2):115-23. PubMed ID: 24982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter controlled trial of fluspirilene and fluphenazine enanthate in chronic schizophrenic syndromes.
    Malm U; Perris C; Rapp W; Wedrén G
    Acta Psychiatr Scand Suppl; 1974; 249():94-116. PubMed ID: 4608506
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparative double-blind trial of fluspirilene and fluphenazine decanoate in the treatment of chronic schizophrenia.
    Winter K; Fullerton AG; Hussain K; Tarlo L
    Br J Clin Pract; 1973 Oct; 27(10):377-80. PubMed ID: 4601614
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical evaluation of pipotiazine palmitate (19.552 R.P.) used on patients in an acute reception ward.
    Elley JH; Petersen JH
    Acta Psychiatr Scand Suppl; 1973; 241():75-82. PubMed ID: 4147514
    [No Abstract]   [Full Text] [Related]  

  • 18. Penfluridol: a double blind trial in chronic schizophrenia.
    James NM
    N Z Med J; 1977 Jan; 85(580):53-4. PubMed ID: 322000
    [No Abstract]   [Full Text] [Related]  

  • 19. A study of flupenthixol decanoate and pipotiazine undecylenate in schizophrenics.
    Astrup C; Grimgård A; Hebnes K; Kruse-Jensen A; Lid M
    Acta Psychiatr Scand; 1974; 50(5):481-91. PubMed ID: 4156624
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical experience with pipotiazine palmitate (19.552 R.P.) in Nordic countries. Report of a multicentre investigation.
    Kristjansen P; Dencker SJ; Elley J; Hakola A; Heshe J; Malm U; Robak OH; Salvesen C; Vaksdal K
    Acta Psychiatr Scand Suppl; 1973; 241():51-6. PubMed ID: 4147511
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.